1. Home
  2. BARK vs COEP Comparison

BARK vs COEP Comparison

Compare BARK & COEP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo BARK Inc.

BARK

BARK Inc.

HOLD

Current Price

$9.76

Market Cap

92.7M

ML Signal

HOLD

Logo Coeptis Therapeutics Holdings Inc.

COEP

Coeptis Therapeutics Holdings Inc.

HOLD

Current Price

$16.40

Market Cap

91.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BARK
COEP
Founded
2011
2017
Country
United States
United States
Employees
N/A
6
Industry
Department/Specialty Retail Stores
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
92.7M
91.2M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
BARK
COEP
Price
$9.76
$16.40
Analyst Decision
Buy
Analyst Count
2
0
Target Price
$37.50
N/A
AVG Volume (30 Days)
40.3K
92.3K
Earning Date
06-03-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$2.43
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.50
$6.80
52 Week High
$11.00
$21.41

Technical Indicators

Market Signals
Indicator
BARK
COEP
Relative Strength Index (RSI) 59.25 72.18
Support Level $8.25 $13.77
Resistance Level $9.84 $19.19
Average True Range (ATR) 0.66 1.15
MACD -0.02 0.47
Stochastic Oscillator 69.28 87.62

Price Performance

Historical Comparison
BARK
COEP

About BARK BARK Inc.

BARK Inc is a vertically integrated, omnichannel brand serving dogs across two key categories: toys & accessories and consumables. It serves dogs nationwide with monthly subscription services, BarkBox and Super Chewer; e-commerce experience on BarkShop.com; custom collections via its retail partner network, including Target and Amazon; wellness products that meet dogs' needs with BARK Bright; and a personalized meal delivery service for dogs BARK Eats. The company's reportable segments are; Direct to Consumer (D2C), and Commerce. The majority of its revenue is generated from the Direct to Consumer segment which derives revenue from the sale of toys & accessories and consumables through BarkBox, Super Chewer, and the company's consumables website.

About COEP Coeptis Therapeutics Holdings Inc.

Coeptis Therapeutics Holdings Inc is a biopharmaceutical and technology company. The biopharmaceutical division focuses on developing cell therapy platforms for cancer, autoimmune, and infectious diseases. Coeptis aims to advance treatment paradigms and improve patient outcomes through its research and development efforts. The technology division focuses on enhancing operational capabilities through technologies. This division features AI-powered marketing software and robotic process automation tools designed to optimize business processes and improve overall efficiency. It derives the majority of the revenue from the Technology segment.

Share on Social Networks: